| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 159, Issue 7 3364-3371, Copyright © 1997 by American Association of Immunologists
ARTICLES |
MB Glaccum, KL Stocking, K Charrier, JL Smith, CR Willis, C Maliszewski, DJ Livingston, JJ Peschon and PJ Morrissey
Immunex Corporation, Seattle, WA 98101, USA.
IL-1 alpha and IL-1 beta bind to receptors termed the type I and type II IL-1 receptors. The type I IL-1 receptor is responsible for specific signaling, while the type II IL-1 receptor functions as a nonsignaling decoy receptor. To determine the effect of a defect in IL-1-mediated signaling, mice have been produced with a genetically disrupted type I IL-1 receptor gene. Mice lacking type I IL-1 receptors are of normal vigor and exhibit no overt phenotype. B cells from type I IL-1R-/- mice activated in vitro with anti-IgM do not proliferate in response to IL- 1, but do so in response to IL-4. Injection of murine IL-1 alpha does not induce detectable serum IL-6 levels in type I IL-1R-/- mice, but equivalent levels are produced in response to LPS. Type I IL-1R-/- mice have normal serum Ig levels and generate equivalent primary and secondary Ab responses as wild-type mice. In response to LPS, acute phase protein mRNA induction are equivalent in type I IL-1R-/- and wild- type mice. Type I IL-1R-/- mice do not differ from control mice in susceptibility to either a lethal challenge with D-galactosamine plus LPS or high dose LPS. Interestingly, ICE-/-/type I IL-1R-/- double mutant mice are resistant to high dose LPS. Type I IL-1R-/- mice backcrossed to the C57BL/6 background were as equally resistant as wild- type mice to Listeria monocytogenes.
This article has been cited by other articles:
|
|
 |
|
  C. Orelio, E. Haak, M. Peeters, and E. Dzierzak Interleukin-1-mediated hematopoietic cell regulation in the aorta-gonad-mesonephros region of the mouse embryo Blood, December 15, 2008; 112(13): 4895 - 4904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Babcock, H. Toft-Hansen, and T. Owens Signaling through MyD88 Regulates Leukocyte Recruitment after Brain Injury J. Immunol., November 1, 2008; 181(9): 6481 - 6490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Brinster and E. M. Shevach Costimulatory effects of IL-1 on the expansion/differentiation of CD4+CD25+Foxp3+ and CD4+CD25+Foxp3- T cells J. Leukoc. Biol., August 1, 2008; 84(2): 480 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Gratz, M. Siller, B. Schaljo, Z. A. Pirzada, I. Gattermeier, I. Vojtek, C. J. Kirschning, H. Wagner, S. Akira, E. Charpentier, et al. Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9 J. Biol. Chem., July 18, 2008; 283(29): 19879 - 19887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Koo and R. S. Duman IL-1 is an essential mediator of the antineurogenic and anhedonic effects of stress PNAS, January 15, 2008; 105(2): 751 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Blumberg, H. Dinh, E. S. Trueblood, J. Pretorius, D. Kugler, N. Weng, S. T. Kanaly, J. E. Towne, C. R. Willis, M. K. Kuechle, et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation J. Exp. Med., October 29, 2007; 204(11): 2603 - 2614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Bunt, L. Yang, P. Sinha, V. K. Clements, J. Leips, and S. Ostrand-Rosenberg Reduced Inflammation in the Tumor Microenvironment Delays the Accumulation of Myeloid-Derived Suppressor Cells and Limits Tumor Progression Cancer Res., October 15, 2007; 67(20): 10019 - 10026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Johnston, J. P. Mizgerd, L. Flynt, L. J. Quinton, E. S. Williams, and S. A. Shore Type I Interleukin-1 Receptor Is Required for Pulmonary Responses to Subacute Ozone Exposure in Mice Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 477 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Fogal, J. Li, D. Lobner, L. D. McCullough, and S. J. Hewett System xc Activity and Astrocytes Are Necessary for Interleukin-1{beta}-Mediated Hypoxic Neuronal Injury J. Neurosci., September 19, 2007; 27(38): 10094 - 10105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Glasgow, S. Ramachandran, T. S. Blackwell, T. Mohanakumar, and W. C. Chapman Interleukin-1beta is the primary initiator of pulmonary inflammation following liver injury in mice Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L491 - L496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Guay, T. A. Andreyeva, R. L. Garcea, R. M. Welsh, and E. Szomolanyi-Tsuda MyD88 Is Required for the Formation of Long-Term Humoral Immunity to Virus Infection J. Immunol., April 15, 2007; 178(8): 5124 - 5131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Deckert, S. Virna, M. Sakowicz-Burkiewicz, S. Lutjen, S. Soltek, H. Bluethmann, and D. Schluter Interleukin-1 Receptor Type 1 Is Essential for Control of Cerebral but Not Systemic Listeriosis Am. J. Pathol., March 1, 2007; 170(3): 990 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Chen, G. Sen, and C. M. Snapper Endogenous IL-1R1 Signaling Is Critical for Cognate CD4+ T Cell Help for Induction of In Vivo Type 1 and Type 2 Antipolysaccharide and Antiprotein Ig Isotype Responses to Intact Streptococcus pneumoniae, but Not to a Soluble Pneumococcal Conjugate Vaccine J. Immunol., November 1, 2006; 177(9): 6044 - 6051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Garcia, I. Wernstedt, A. Berndtsson, M. Enge, M. Bell, O. Hultgren, M. Horn, B. Ahren, S. Enerback, C. Ohlsson, et al. Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes, May 1, 2006; 55(5): 1205 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nambu, S. Nakae, and Y. Iwakura IL-1{beta}, but not IL-1{alpha}, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses Int. Immunol., May 1, 2006; 18(5): 701 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chamberlain, D. Evans, A. King, R. Dewberry, S. Dower, D. Crossman, and S. Francis Interleukin-1{beta} and Signaling of Interleukin-1 in Vascular Wall and Circulating Cells Modulates the Extent of Neointima Formation in Mice Am. J. Pathol., April 1, 2006; 168(4): 1396 - 1403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Noulin, V. F. J. Quesniaux, S. Schnyder-Candrian, B. Schnyder, I. Maillet, T. Robert, B. B. Vargaftig, B. Ryffel, and I. Couillin Both Hemopoietic and Resident Cells Are Required for MyD88-Dependent Pulmonary Inflammatory Response to Inhaled Endotoxin J. Immunol., November 15, 2005; 175(10): 6861 - 6869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schnyder-Candrian, V. F. J. Quesniaux, F. Di Padova, I. Maillet, N. Noulin, I. Couillin, R. Moser, F. Erard, B. B. Vargaftig, B. Ryffel, et al. Dual Effects of p38 MAPK on TNF-Dependent Bronchoconstriction and TNF-Independent Neutrophil Recruitment in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome J. Immunol., July 1, 2005; 175(1): 262 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shepherd and M. J.H. Nicklin Elastic-Vessel Arteritis in Interleukin-1 Receptor Antagonist-Deficient Mice Involves Effector Th1 Cells and Requires Interleukin-1 Receptor Circulation, June 14, 2005; 111(23): 3135 - 3140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Schmitz, M. Kurrer, M. F. Bachmann, and M. Kopf Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection J. Virol., May 15, 2005; 79(10): 6441 - 6448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pande, S. M. Moran, and C. A. Bradfield Aspects of Dioxin Toxicity Are Mediated by Interleukin 1-Like Cytokines Mol. Pharmacol., May 1, 2005; 67(5): 1393 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Li and C. D. Klaassen Lipopolysaccharide-Induced Down-Regulation of Organic Anion Transporting Polypeptide 4 (Oatp4; Slc21a10) Is Independent of Tumor Necrosis Factor-{alpha}, Interleukin-1{beta}, Interleukin-6, or Inducible Nitric Oxide Synthase Toxicol. Sci., January 1, 2005; 83(1): 197 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chi, E. Messas, R. A. Levine, D. T. Graves, and S. Amar Interleukin-1 Receptor Signaling Mediates Atherosclerosis Associated With Bacterial Exposure and/or a High-Fat Diet in a Murine Apolipoprotein E Heterozygote Model: Pharmacotherapeutic Implications Circulation, September 21, 2004; 110(12): 1678 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Silverstein Review: D-Galactosamine lethality model: scope and limitations Innate Immunity, June 1, 2004; 10(3): 147 - 162. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Torres, M. Barrier, F. Bihl, V. J. F. Quesniaux, I. Maillet, S. Akira, B. Ryffel, and F. Erard Toll-Like Receptor 2 Is Required for Optimal Control of Listeria monocytogenes Infection Infect. Immun., April 1, 2004; 72(4): 2131 - 2139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Timoshanko, A. R. Kitching, Y. Iwakura, S. R. Holdsworth, and P. G. Tipping Contributions of IL-1{beta} and IL-1{alpha} to Crescentic Glomerulonephritis in Mice J. Am. Soc. Nephrol., April 1, 2004; 15(4): 910 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Thomas, W. Irawaty, R. Darwiche, T. C. Brodnicki, P. Santamaria, J. Allison, and T. W.H. Kay IL-1 Receptor Deficiency Slows Progression to Diabetes in the NOD Mouse Diabetes, January 1, 2004; 53(1): 113 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Islam and J. J. Pestka Role of IL-1{beta} in Endotoxin Potentiation of Deoxynivalenol-Induced Corticosterone Response and Leukocyte Apoptosis in Mice Toxicol. Sci., July 1, 2003; 74(1): 93 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. G. Zwijnenburg, T. van der Poll, S. Florquin, J. J. Roord, and A. M. van Furth IL-1 Receptor Type 1 Gene-Deficient Mice Demonstrate an Impaired Host Defense Against Pneumococcal Meningitis J. Immunol., May 1, 2003; 170(9): 4724 - 4730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Hefler, E. Ludwig, A. Lebrecht, R. Zeillinger, D. Tong-Cacsire, H. Koelbl, S. Leodolter, and C. B. Tempfer Polymorphisms of the Interleukin-1 Gene Cluster and Ovarian Cancer Reproductive Sciences, November 1, 2002; 9(6): 386 - 390. [Abstract] [PDF]
|
|
|
|
|
|
C. L. Parish, D. I. Finkelstein, W. Tripanichkul, A. R. Satoskar, J. Drago, and M. K. Horne The Role of Interleukin-1, Interleukin-6, and Glia in Inducing Growth of Neuronal Terminal Arbors in Mice J. Neurosci., September 15, 2002; 22(18): 8034 - 8041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-K. Lee, J. Kalinowski, S. Jastrzebski, and J. A. Lorenzo 1,25 (OH)2 Vitamin D3-Stimulated Osteoclast Formation in Spleen-Osteoblast Cocultures Is Mediated in Part by Enhanced IL-1{alpha} and Receptor Activator of NF-{kappa}B Ligand Production in Osteoblasts J. Immunol., September 1, 2002; 169(5): 2374 - 2380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Basu, J. K. Krady, M. O'Malley, S. D. Styren, S. T. DeKosky, and S. W. Levison The Type 1 Interleukin-1 Receptor Is Essential for the Efficient Activation of Microglia and the Induction of Multiple Proinflammatory Mediators in Response to Brain Injury J. Neurosci., July 15, 2002; 22(14): 6071 - 6082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Noursadeghi, M. C. M. Bickerstaff, J. Herbert, D. Moyes, J. Cohen, and M. B. Pepys Production of Granulocyte Colony-Stimulating Factor in the Nonspecific Acute Phase Response Enhances Host Resistance to Bacterial Infection J. Immunol., July 15, 2002; 169(2): 913 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li, A. Khansari, L. Shapira, D. T. Graves, and S. Amar Contribution of Interleukin-11 and Prostaglandin(s) in Lipopolysaccharide-Induced Bone Resorption In Vivo Infect. Immun., July 1, 2002; 70(7): 3915 - 3922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ji, A. Pettit, K. Ohmura, A. Ortiz-Lopez, V. Duchatelle, C. Degott, E. Gravallese, D. Mathis, and C. Benoist Critical Roles for Interleukin 1 and Tumor Necrosis Factor {alpha} in Antibody-induced Arthritis J. Exp. Med., July 1, 2002; 196(1): 77 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Irikura, M. Lagraoui, and D. Hirsh The Epistatic Interrelationships of IL-1, IL-1 Receptor Antagonist, and the Type I IL-1 Receptor J. Immunol., July 1, 2002; 169(1): 393 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Perregaux, K. Bhavsar, L. Contillo, J. Shi, and C. A. Gabel Antimicrobial Peptides Initiate IL-1{beta} Posttranslational Processing: A Novel Role Beyond Innate Immunity J. Immunol., March 15, 2002; 168(6): 3024 - 3032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Touzani, H. Boutin, R. LeFeuvre, L. Parker, A. Miller, G. Luheshi, and N. Rothwell Interleukin-1 Influences Ischemic Brain Damage in the Mouse Independently of the Interleukin-1 Type I Receptor J. Neurosci., January 1, 2002; 22(1): 38 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Rijneveld, S. Florquin, J. Branger, P. Speelman, S. J. H. Van Deventer, and T. van der Poll TNF-{alpha} Compensates for the Impaired Host Defense of IL-1 Type I Receptor-Deficient Mice During Pneumococcal Pneumonia J. Immunol., November 1, 2001; 167(9): 5240 - 5246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Graves, N. Nooh, T. Gillen, M. Davey, S. Patel, D. Cottrell, and S. Amar IL-1 Plays a Critical Role in Oral, But Not Dermal, Wound Healing J. Immunol., November 1, 2001; 167(9): 5316 - 5320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Donnelly, C. E. Loscher, M. A. Lynch, and K. H. G. Mills Whole-Cell but Not Acellular Pertussis Vaccines Induce Convulsive Activity in Mice: Evidence of a Role for Toxin-Induced Interleukin-1{beta} in a New Murine Model for Analysis of Neuronal Side Effects of Vaccination Infect. Immun., July 1, 2001; 69(7): 4217 - 4223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nakae, M. Asano, R. Horai, N. Sakaguchi, and Y. Iwakura IL-1 Enhances T Cell-Dependent Antibody Production Through Induction of CD40 Ligand and OX40 on T Cells J. Immunol., July 1, 2001; 167(1): 90 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Mizgerd, M. R. Spieker, and C. M. Doerschuk Early Response Cytokines and Innate Immunity: Essential Roles for TNF Receptor 1 and Type I IL-1 Receptor During Escherichia coli Pneumonia in Mice J. Immunol., March 15, 2001; 166(6): 4042 - 4048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Boelens, T. van der Poll, S. A. J. Zaat, J. L. A. N. Murk, J. J. Weening, and J. Dankert Interleukin-1 Receptor Type I Gene-Deficient Mice Are Less Susceptible to Staphylococcus epidermidis Biomaterial-Associated Infection than Are Wild-Type Mice Infect. Immun., December 1, 2000; 68(12): 6924 - 6931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Grcevic, S.-K. Lee, A. Marusic, and J. A. Lorenzo Depletion of CD4 and CD8 T Lymphocytes in Mice In Vivo Enhances 1,25-Dihydroxyvitamin D3-Stimulated Osteoclast-Like Cell Formation In Vitro by a Mechanism That Is Dependent on Prostaglandin Synthesis J. Immunol., October 15, 2000; 165(8): 4231 - 4238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Lomaga, J. T. Henderson, A. J. Elia, J. Robertson, R. S. Noyce, W.-C. Yeh, and T. W. Mak Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) Deficiency Results in Exencephaly and Is Required for Apoptosis within the Developing CNS J. Neurosci., October 1, 2000; 20(19): 7384 - 7393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Graves, C.-P. Chen, C. Douville, and Y. Jiang Interleukin-1 Receptor Signaling Rather than That of Tumor Necrosis Factor Is Critical in Protecting the Host from the Severe Consequences of a Polymicrobe Anaerobic Infection Infect. Immun., August 1, 2000; 68(8): 4746 - 4751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. JUFFERMANS, A. VERBON, J. T. BELISLE, P. J. HILL, P. SPEELMAN, S. J. H. van DEVENTER, and T. van der POLL Mycobacterial Lipoarabinomannan Induces an Inflammatory Response in the Mouse Lung . A Role for Interleukin-1 Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 486 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hochholzer, G. B. Lipford, H. Wagner, K. Pfeffer, and K. Heeg Role of Interleukin-18 (IL-18) during Lethal Shock: Decreased Lipopolysaccharide Sensitivity but Normal Superantigen Reaction in IL-18-Deficient Mice Infect. Immun., June 1, 2000; 68(6): 3502 - 3508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J.H. Nicklin, D. E. Hughes, J. L. Barton, J. M. Ure, and G. W. Duff Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene J. Exp. Med., January 17, 2000; 191(2): 303 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Broide, K. Campbell, T. Gifford, and P. Sriramarao Inhibition of eosinophilic inflammation in allergen-challenged, IL-1 receptor type 1-deficient mice is associated with reduced eosinophil rolling and adhesion on vascular endothelium Blood, January 1, 2000; 95(1): 263 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-P. Chen, M. Hertzberg, Y. Jiang, and D. T. Graves Interleukin-1 and Tumor Necrosis Factor Receptor Signaling Is Not Required for Bacteria-Induced Osteoclastogenesis and Bone Loss but Is Essential for Protecting the Host from a Mixed Anaerobic Infection Am. J. Pathol., December 1, 1999; 155(6): 2145 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Brito, L. M. O’Rourke, Y. Pan, J. Anglin, S. R. Planck, and J. T. Rosenbaum IL-1 and TNF Receptor-Deficient Mice Show Decreased Inflammation in an Immune Complex Model of Uveitis Invest. Ophthalmol. Vis. Sci., October 1, 1999; 40(11): 2583 - 2589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-Y. Chiang, G. Kyritsis, D. T. Graves, and S. Amar Interleukin-1 and Tumor Necrosis Factor Activities Partially Account for Calvarial Bone Resorption Induced by Local Injection of Lipopolysaccharide Infect. Immun., August 1, 1999; 67(8): 4231 - 4236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. N. Luheshi, J. D. Gardner, D. A. Rushforth, A. S. Loudon, and N. J. Rothwell Leptin actions on food intake and body temperature are mediated by IL-1 PNAS, June 8, 1999; 96(12): 7047 - 7052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Blaukat, I. Ivankovic-Dikic, E. Gronroos, F. Dolfi, G. Tokiwa, K. Vuori, and I. Dikic Adaptor Proteins Grb2 and Crk Couple Pyk2 with Activation of Specific Mitogen-activated Protein Kinase Cascades J. Biol. Chem., May 21, 1999; 274(21): 14893 - 14901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Lomaga, W.-C. Yeh, I. Sarosi, G. S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman, et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling Genes & Dev., April 15, 1999; 13(8): 1015 - 1024. [Abstract] [Full Text]
|
|
|
|
|
|
W. E. Carson, H. Yu, J. Dierksheide, K. Pfeffer, P. Bouchard, R. Clark, J. Durbin, A. S. Baldwin, J. Peschon, P. R. Johnson, et al. A Fatal Cytokine-Induced Systemic Inflammatory Response Reveals a Critical Role for NK Cells J. Immunol., April 15, 1999; 162(8): 4943 - 4951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Irikura, E. Hirsch, and D. Hirsh Effects of Interleukin-1 Receptor Antagonist Overexpression on Infection by Listeria monocytogenes Infect. Immun., April 1, 1999; 67(4): 1901 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
